7*24 Hotline：
Guizhou Xinbang Pharmaceutical Co., Ltd. (002390)
Guizhou Xinbang Pharmaceutical Co., Ltd. was established in January 1995 with its registered office in Luodian County, Guizhou Province and its management headquarters in Guiyang city. In April 2010, the company was successfully listed on Shenzhen Stock Exchange, stock code: 002390.
At present, the company has a registered capital of 1.667 billion yuan, more than 30 holding enterprises and nearly 6000 employees. It has developed into a whole industry chain enterprise group integrating medical services, pharmaceutical circulation and pharmaceutical industry. As of 2019, the total assets of the company is 10.419 billion yuan, and the operating revenue is 6.655 billion yuan, with a year-on-year growth of 1.14%; The net profit was 236 million yuan, and the business performance kept rising steadily.
In the medical service sector, under the strategic planning of building a high-tech medical group, the company always adheres to the concept of "patient-centered", the standardized and scientific hospital management idea, the operation of combining scientific research, teaching and medical treatment, and constantly improves the level of diagnosis and treatment and the quality of medical service by introducing high-end talents, cutting-edge technology and advanced equipment, To meet the growing diversified health needs of the people. The company has continued to develop in medical teaching and research and discipline construction.
The company has Guizhou Cancer Hospital, Baiyun Hospital Affiliated to Guizhou Medical University, Wudang Hospital Affiliated to Guizhou Medical University, Anshun Hospital of Guizhou Medical University, Renhuai new Chaoyang Hospital, Liuzhi Boda hospital, Liupanshui Anju hospital and other medical institutions, which are distributed in Guiyang, Zunyi, Anshun, Liupanshui and other places, with nearly 6000 beds, And through the internet medical service platform of "Guiyi cloud" and "Zunyi cloud hospital", the comprehensive medical layout online and offline is realized.
The company has accumulated rich experience in hospital operation and management in practice, and has a relatively stable team of experts and scientists. The company will strictly follow the idea of sustainable growth, grasp the main tone of healthy development, and gradually realize the output of talent team, discipline construction and management team for the group's medical service institutions based on tumor hospital and Baiyun hospital, so as to achieve the company's goal of medical service scale.
In the pharmaceutical circulation sector, the company has more than 20 circulation companies, such as Kekai pharmaceutical, Zhuoda pharmaceutical, Xinbang pharmaceutical, Kekai pharmacy, xindali biotechnology company, Zhongkang zeai medical equipment company, etc., which are mainly engaged in the sales and distribution services of drugs and medical equipment, with tens of thousands of varieties, basically covering the purchase demand of Grade-A hospitals, and has formed a system with Guiyang as the center, covering southern Guizhou, Southern Guizhou and Western Guizhou Zunyi, Bijie, Tongren and other key areas radiate the distribution network of the whole province.
The company will further improve the level of distribution service, optimize the efficiency of distribution, ensure the quality of distribution, meet the market demand through diversified and all-round medical circulation and supporting services, and continue to expand business coverage to achieve large-scale and intensive operation.
In the pharmaceutical industry sector, the company's business covers many fields such as the cultivation of Chinese herbal medicine, the production and sales of Chinese herbal pieces and Chinese patent medicines, forming a closed industrial chain. In terms of Chinese patent medicine, it has 5 GMP production lines, 41 national drug brand varieties, 3 national high-quality and good price varieties, 2 protected varieties of traditional Chinese medicine, 6 exclusive varieties, Maixuekang capsule, Yixinshu capsule and other competitive products have won the title of "famous brand product of Guizhou Province" for many times.
Adhering to the corporate philosophy of "sincerity, common aspiration, healthy people, and development of people's livelihood", and practicing the core values of "honest cooperation, realistic innovation, and pursuit of results", the company adheres to honest operation and innovative development, has been listed in the public praise list of China's listed companies, and has won the titles of "the most growing listed company" and "the best business model listed company" respectively, In 2018, it ranked 36th in the top 100 enterprises and 3rd in the top 100 private enterprises; In 2019, it will be ranked 34th among the top 100 enterprises, 3rd among the top 100 private enterprises and 13th among the top 100 manufacturing enterprises; In 2020, it will rank 32nd among the top 100 enterprises, 5th among the top 100 private enterprises and 11th among the top 100 manufacturing enterprises, and continue to lead the pharmaceutical industry in Guizhou Province.
The company will make full use of the capital market, organically combine the endogenous development with the extensive merger and acquisition, work hard in innovation and management, and constantly become bigger and stronger, striving to become a high-tech medical group!
oil wellhead